Laurion Capital Management LP Cyma Bay Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $12.8 Million - $18.7 Million	-1,707,747 Reduced 88.85%	214,356 $2.35 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $1.8 Million - $2.94 Million	306,203 Added 18.95%	1,922,103 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $112,547 - $172,681	40,631 Added 2.58%	1,615,900 $5.66 Million
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $2.71 Million - $5.34 Million	1,575,269 New	1,575,269 $4.65 Million
Q2 2018 Aug 13, 2018	SELL	$10.66 - $14.38 $538,969 - $727,052	-50,560 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$9.0 - $15.16 $455,040 - $766,489	50,560 New	50,560 $657,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.